electroCore (ECOR) vs Vivani Medical (VANI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
electroCore (ECOR) has outperformed Vivani Medical (VANI) over the past year, losing 6.2% versus a loss of 13.6%. Over five years, ECOR leads with a -61.2% price change compared with -81.8% for VANI. Vivani Medical is the larger company by market cap ($102.8 million vs $40.8 million), about 2.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ECOR | VANI |
|---|---|---|
| Share price | $4.42 | $1.14 |
| Market cap | $40.78M | $102.83M |
| 1-day change | -8.87% | +4.59% |
| YTD return | -1.45% | -7.32% |
| 1-year return | -6.16% | -13.64% |
| 5-year return | -61.23% | -81.82% |
| EPS (TTM) | $-1.36 | $-0.33 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $32.03M | $0 |
| Revenue growth (YoY) | +27.20% | — |
| Net income (latest FY) | $-13.97M | $-26.61M |
| Gross margin | 86.75% | — |
| Operating margin | -41.06% | — |
| Net margin | -43.60% | — |
| 52-week high | $12.70 | $1.66 |
| 52-week low | $3.90 | $0.80 |
| Distance from 52-week high | -65.20% | -31.37% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +333.71% | +235.96% |
| Average volume | 120.32K | 228.83K |
| Shares outstanding | 9.23M | 90.20M |
| Employees | 83 | 42 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Vivani Medical is about 2.5 times larger than electroCore by market value ($102.83M vs $40.78M).
About electroCore
ECOR stock →electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 83 employees
About Vivani Medical
VANI stock →Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 42 employees
ECOR vs VANI FAQ
Which is bigger, electroCore or Vivani Medical?
Vivani Medical (VANI) is larger, with a market capitalization of $102.83M compared with $40.78M for electroCore (ECOR).
Which stock has performed better over the past year, ECOR or VANI?
ECOR returned -6.16% over the past 12 months, compared with -13.64% for VANI (price return, excluding dividends). Past performance does not predict future results.
Are electroCore and Vivani Medical in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.